Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D.G. Altman, K.F. Schulz, D. Moher, M. Egger, F. Davidoff, D. Elbourne, et al.
The revised CONSORT statement for reporting randomized trials: explanation and elaboration.
Ann Intern Med, 134 (2001), pp. 663-694
[2.]
M.L. Mahowald, J.A. Singh, P. Majeski.
Opioid use by patients in an orthopedics spine clinic.
Arthritis Rheum, 52 (2005), pp. 312-321
[3.]
S.R. Ytterberg, M.L. Mahowald, S.R. Woods.
Codeine and oxycodone use in patients with chronic rheumatic disease pain.
Arthritis Rheum, 41 (1998), pp. 1603-1612
[4.]
K. Milligan, M. Lanteri-Minet, K. Borchert, H. Helmers, R. Donald, H.G. Kress, et al.
Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain.
J Pain, 2 (2001), pp. 197-204
[5.]
K. Mystakidou, E. Parpa, E. Tsilika, A. Mavromati, V. Smyrniotis, S. Georgaki, et al.
Long-term management of noncancer pain with transdermal therapeutic system-fentanyl.
J Pain, 4 (2003), pp. 298-306
[6.]
R.N. Jamison, S.A. Raymond, E.A. Slawsby, S.S. Nedeljkovic, N.P. Katz.
Opioid therapy for chronic noncancer back pain. A randomized prospective study.
Spine, 23 (1998), pp. 2591-2600
[7.]
R.T. Salzman, M.S. Roberts, J. Wild, C. Fabian, R.F. Reder, P.D. Goldenheim.
Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?.
J Pain Symptom Manage, 18 (1999), pp. 271-279
[8.]
C.J. Andrews, L. Cohen, R.B. Crail, G. Douch, M.G. Sheldon, K.A. Wray.
A trial of Fortagesic and Paramol 118 in osteoarthritis.
J Int Med Res, 4 (1976), pp. 432-434
[9.]
D.E. Moulin, A. Iezzi, R. Amireh, W.K. Sharpe, D. Boyd, H. Merskey.
Randomised trial of oral morphine for chronic non-cancer pain.
Lancet, 347 (1996), pp. 143-147
[10.]
M. Palangio, E. Morris, R.T. Doyle Jr, B.E. Dornseif, T.J. Valente.
Combination hydrocodone and ibuprofen versus combination oxycodone and acetaminophen in the treatment of moderate or severe acute low back pain.
Clin Ther, 24 (2002), pp. 87-99
[11.]
P.M. Peloso, N. Bellamy, W. Bensen, G.T. Thomson, Z. Harsanyi, N. Babul, et al.
Double blind randomized placebo control trial of controlled release codeine in the treatment of osteoarthritis of the hip or knee.
J Rheumatol, 27 (2000), pp. 764-771
[12.]
J. Russell, M. Kamin, R.M. Bennett, T.J. Schnitzer, J.A. Green, W.A. Katz.
Efficacy of tramadol in treatment of pain in fibromyalgia.
JCR J Clin Rheumatol, 6 (2000), pp. 250-257
[13.]
B. Bodalia, C.J. McDonald, K.J. Smith, C. O’Brien, L. Cousens.
A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules.
J Pain Symptom Manage, 25 (2003), pp. 142-149
[14.]
J.R. Caldwell, M.E. Hale, R.E. Boyd, J.M. Hague, T. Iwan, M. Shi, et al.
Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal anti-inflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial.
J Rheumatol, 26 (1999), pp. 862-869
[15.]
J.R. Caldwell, R.J. Rapoport, J.C. Davis, H.L. Offenberg, H.W. Marker, S.H. Roth, et al.
Efficacy and safety of a once-daily morphine formulation in chronic, moderate-to-severe osteoarthritis pain: results from a randomized, placebo-controlled, double-blind trial and an open-label extension trial.
J Pain Symptom Manage, 23 (2002), pp. 278-291
[16.]
R.S. Lloyd, F. Costello, M.J. Eves, I.G. James, A.J. Miller.
The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hips.
Curr Med Res Opin, 13 (1992), pp. 37-48
[17.]
W. Arkinstall, A. Sandler, B. Goughnour, N. Babul, Z. Harsanyi, A.C. Darke.
Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial.
Pain, 62 (1995), pp. 169-178
[18.]
N. Babul, R. Noveck, H. Chipman, S.H. Roth, T. Gana, K. Albert.
Efficacy and safety of extended-release, once-daily tramadol in chronic pain: a randomized 12-week clinical trial in osteoarthritis of the knee.
J Pain Symptom Manage, 28 (2004), pp. 59-71
[19.]
H. Malonne, M. Coffiner, B. Sonet, A. Sereno, F. Vanderbist.
Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
Clin Ther, 26 (2004), pp. 1774-1782
[20.]
G. Mongin, V. Yakusevich, A. Kope, N. Shostak, E. Pikhlak, L. Popdan, et al.
Efficacy and safety assessment of a novel once-daily tablet formulation of tramadol: a randomised, controlled study versus twice-daily tramadol in patients with osteoarthritis of the knee.
Clin Drug Invest, 24 (2004), pp. 545-558
[21.]
G.E. Ruoff.
Slowing the initial titration rate of tramadol improves tolerability.
Pharmacotherapy, 19 (1999), pp. 88-93
[22.]
T.J. Schnitzer, W.L. Gray, R.Z. Paster, M. Kamin.
Efficacy of tramadol in treatment of chronic low back pain.
J Rheumatol, 27 (2000), pp. 772-778
[23.]
R.M. Bennett, M. Kamin, R. Karim, N. Rosenthal.
Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study.
Am J Med, 114 (2003), pp. 537-545
[24.]
R. Emkey, N. Rosenthal, S.C. Wu, D. Jordan, M. Kamin.
Efficacy and safety of tramadol/acetaminophen tablets (Ultracet) as add-on therapy for osteoarthritis pain in subjects receiving a COX-2 nonsteroidal anti-inflammatory drug: a multicenter, randomized, double-blind, placebo-controlled trial.
J Rheumatol, 31 (2004), pp. 150-156
[25.]
P.M. Peloso, L. Fortin, A. Beaulieu, M. Kamin, N. Rosenthal.
Analgesic efficacy and safety of tramadol/ acetaminophen combination tablets (Ultracet) in treatment of chronic low back pain: a multicenter, outpatient, randomized, double blind, placebo controlled trial.
J Rheumatol, 31 (2004), pp. 2454-2463
[26.]
G.E. Ruoff, N. Rosenthal, D. Jordan, R. Karim, M. Kamin.
Tramadol/acetaminophen combination tablets for the treatment of chronic lower back pain: a multicenter, randomized, double-blind, placebo-controlled outpatient study.
Clin Ther, 25 (2003), pp. 1123-1141
[28.]
S.H. Roth, R.M. Fleischmann, F.X. Burch, F. Dietz, B. Bockow, R.J. Rapoport, et al.
Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation.
Arch Intern Med, 160 (2000), pp. 853-860
[29.]
W.S. Mullican, J.R. Lacy.
Tramadol/acetaminophen combination tablets and codeine/acetaminophen combination capsules for the management of chronic pain: a comparative trial.
Clin Ther, 23 (2001), pp. 1429-1445
[30.]
P. Kjaersgaard-Andersen, A. Nafei, O. Skov, F. Madsen, H.M. Andersen, K. Kroner, et al.
Codeine plus paracetamol versus paracetamol in longerterm treatment of chronic pain due to osteoarthritis of the hip. A randomised, double-blind, multi-centre study.
Pain, 43 (1990), pp. 309-318
[31.]
L. Adler, C. McDonald, C. O’Brien, M. Wilson.
A comparison of oncedaily tramadol with normal release tramadol in the treatment of pain in osteoarthritis.
J Rheumatol, 29 (2002), pp. 2196-2199
[32.]
M. Raber, S. Hofmann, K. Junge, H. Momberger, D. Kuhn.
Analgesic efficacy and tolerability of tramadol 100 mg sustained-release capsules in patients with moderate to severe chronic low back pain.
Clin Drug Invest, 17 (1999), pp. 415-423
[33.]
J. Sorge, T.H. Stadler.
Comparison of the analgesic efficacy and tolerability of tramadol 100 mg sustained-release tablets and tramadol 50 mg capsules for the treatment of chronic low back pain.
Clin Drug Invest, 14 (1997), pp. 157-164
[34.]
L. Allan, H. Hays, N.H. Jensen, B.L. De Waroux, M. Bolt, R. Donald, et al.
Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.
BMJ, 322 (2001), pp. 1154-1158
[35.]
S.H. Roth.
Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis.
J Rheumatol, 25 (1998), pp. 1358-1363
[37.]
J. Glowinski, E. Boccard.
Placebo-controlled study of the analgesic efficacy of a paracetamol 500 mg/codeine 30 mg combination together with lowdose vs high-dose diclofenac in rheumatoid arthritis.
Clin Drug Invest, 18 (1999), pp. 189-197
[38.]
K. Pavelka, Z. Peliskova, H. Stehlikova, S. Ratcliffe, C. Repas.
Intraindividual differences in pain relief and functional improvement in osteoarthritis with diclofenac or tramadol.
Clin Drug Invest, 16 (1998), pp. 421-429
[39.]
F.L. Brown Jr, S. Bodison, J. Dixon, W. Davis, J. Nowoslawski.
Comparison of diflunisal and acetaminophen with codeine in the treatment of initial or recurrent acute low back strain.
Clin Ther, 9 (1986), pp. 52-58
[40.]
R.M. Fleischmann, J.R. Caldwell, S.H. Roth, J.R.P. Tesser, W. Olson, M. Kamin.
Tramadol for the treatment of joint pain associated with osteoarthritis:a randomized, double-blind, placebo-controlled trial.
Curr Ther Res Clin Exp, 62 (2001), pp. 113-128
[41.]
T.J. Cicero, E.H. Adams, A. Geller, J.A. Inciardi, A. Muñoz, S.H. Schnoll, et al.
A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States.
Drug Alcohol Depend, 57 (1999), pp. 7-22
[42.]
T.J. Schnitzer, M. Kamin, W.H. Olson.
Tramadol allows reduction of naproxen dose among patients with naproxen- responsive osteoarthritis pain: a randomized, double-blind, placebo-controlled study.
Arthritis Rheum, 42 (1999), pp. 1370-1377
[43.]
E.M. Jensen, F. Ginsberg.
Tramadol versus dextropropoxyphene in the treatment of osteoarthritis: a short term double-blind study.
Drug Invest, 8 (1994), pp. 211-218
Esta revisión ha contado con el apoyo de la Fundación Española de Reumatología
Copyright © 2006. Elsevier España S.L. Barcelona
